Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-26 @ 6:00 AM
Study NCT ID:
NCT05607160
Status:
COMPLETED
Last Update Posted:
2024-04-12
First Post:
2022-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-31
First Submit QC Date:
None
Study First Post Date:
2022-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-10
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL